Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
deals
8
×
life sciences
national blog main
boston blog main
new york blog main
san diego blog main
startups
boston top stories
clinical trials
san diego top stories
fda
medical device
national top stories
san diego
san francisco blog main
seattle blog main
amgen
bayer
boston
cancer
cancer diagnostics
investing
ipo
merck
new york top stories
novartis
raleigh-durham blog main
san francisco top stories
seattle top stories
the medicines company
10x genomics
480 biomedical
abbvie
achaogen
acquisition
adams street partners
adverum biotechnologies
albert bourla
alirocumab
What
company
8
×
drug
medicines
bacteria
biology
deal
developing
ipo
new
public
san
synthetic
technology
tests
therapeutics
acquire
acquisitions
adding
advance
agreed
aims
albert
based
biggest
billion
bio
biopharma
biotech
bioworks
bourla
brings
business
called
carlsmed
cash
ceo
cholesterol
compound
comprised
crispr
Language
unset
unknown
Current search:
biotech
×
deals
×
company
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections